C5AR1 and Alzheimer disease: The detection of a quantitative enhancement of CD88 in AD brain differs from previous studies that showed either similar neuronal expression of CD88 receptor between control and AD samples[12], or a decrease of the CD88 receptor in neuron populations of AD brains compared to controls[31].